Health Blueprint

Back to Longevity News

News summary

Vitroscope raises $7M to turn living human tissue into a new source of drug discovery data

Source: Tech.eu • Published: 03 Nov 2026, 10:29

Summarized by Masters of Longevity from Tech.eu.

Vitroscope raised $7 million to fund perfusion platforms for living human tissue.

Vitroscope raises $7M to turn living human tissue into a new source of drug discovery data
Key Takeaways
  • Vitroscope is developing automated perfusion platforms for human tissue.
  • The funding was a $5M seed round plus $2M non-dilutive support.
  • Extended perfusion experiments were shown in brain and liver models.
Read the full article at Tech.eu ↗

Continue exploring

Recommended MoL Picks

MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickFrom Metrics to Better LivingEverstride’s May 2026 Consumer Health Market Briefing shows a wellness market moving from products to systems, from tracking to guidance, and from optimization to meaning. The next winners in longevity may not be the companies that measure the most. They may be the ones that help consumers translate health data into a life they actually want to live.